Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 28;14(8):1566.
doi: 10.3390/pharmaceutics14081566.

Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs

Hussein Sabit  1 , Mohamed Abdel-Hakeem  2 , Tahsin Shoala  3 , Shaimaa Abdel-Ghany  3 , Mokhtar Mamdouh Abdel-Latif  4 , Jawaher Almulhim  5 , Mohamed Mansy  4
Affiliations
Review

Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs

Hussein Sabit et al. Pharmaceutics. .

Abstract

Nanomedicines have gained popularity due to their potential therapeutic applications, especially cancer treatment. Targeted nanoparticles can deliver drugs directly to cancer cells and enable prolonged drug release, reducing off-target toxicity and increasing therapeutic efficacy. However, translating nanomedicines from preclinical to clinical settings has been difficult. Rapid advancements in nanotechnology promise to enhance cancer therapies. Nanomedicine offers advanced targeting and multifunctionality. Nanoparticles (NPs) have several uses nowadays. They have been studied as drug transporters, tumor gene delivery agents, and imaging contrast agents. Nanomaterials based on organic, inorganic, lipid, or glycan substances and synthetic polymers have been used to enhance cancer therapies. This review focuses on polymeric nanoparticle delivery strategies for anticancer nanomedicines.

Keywords: anticancer; drug delivery; nanomedicine; polymer nanocarriers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Types of polymeric nanoparticles.
Figure 2
Figure 2
Different types of nanocarriers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Malik D., Mahendiratta S., Kaur H., Medhi B. Futuristic approach to cancer treatment. Gene. 2021;805:145906. doi: 10.1016/j.gene.2021.145906. - DOI - PubMed
    1. Mao J.J., Pillai G.G., Andrade C.J., Ligibel J.A., Basu P., Cohen L., Khan I.A., Mustian K.M., Puthiyedath R., Dhiman K.S., et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J. Clin. 2022;72:144–164. doi: 10.3322/caac.21706. - DOI - PubMed
    1. Karpuz M., Gunay M.S., Ozer A.Y. Current and Future Approaches for Effective Cancer Imaging and Treatment. Cancer Biother. Radiopharm. 2018;33:39–51. doi: 10.1089/cbr.2017.2378. - DOI - PubMed
    1. Naidoo D.B., Chuturgoon A.A. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics. Int. J. Mol. Sci. 2021;22:9778. doi: 10.3390/ijms22189778. - DOI - PMC - PubMed
    1. Garde-Cerdán T., Costa B.S., Rubio-Bretón P., Pérez-Álvarez E.P. Nanotechnology: Recent advances in viticulture and enology. J. Sci. Food Agric. 2021;101:6156–6166. doi: 10.1002/jsfa.11406. - DOI - PubMed

LinkOut - more resources